John M. Kaczmar

Also affiliated with MUSC Hollings Cancer Center

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma”.

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100426

N/A

3.2DataRank · unranked

99 citations

Joshua D. Horton, Sixue Liu, Kent Armeson, John M. Kaczmar, Megan M. Wyatt +21 more

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3351

N/A

0.780DataRank · unranked

180 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew O. Old +21 more

Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6015

N/A

0DataRank · unranked

7 citations

Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia +14 more

Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer

JCO Oncology Practice(2020)10.1200/op.20.00271

N/A

0DataRank · unranked

58 citations

Chanita Hughes Halbert, Hong Li, Graham Warren, Anthony J. Alberg, Elizabeth A. Calhoun +9 more

Evaluation of ICI sensitivity for pembrolizumab in combination with anti-platelet therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (HNSCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6041

N/A

0DataRank · unranked

1 citations

John M. Kaczmar, Brian Riesenberg, Carolyn D. Britten, Alan Brisendine, Elizabeth G. Hill +3 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305.v1

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more